{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:49Z","timestamp":1792090009658,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11177-w","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:41:29Z","timestamp":1788939689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor, germline, and paired testing in oncology: practical considerations"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3047-7610","authenticated-orcid":false,"given":"Xiaojie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-4736","authenticated-orcid":false,"given":"Lisa","family":"Madlensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"4","key":"11177_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016600","volume":"7","author":"R Prakash","year":"2015","unstructured":"Prakash R et al (2015) Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol 7(4):a016600","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11177_CR2","unstructured":"Schneider K et al (1993) Li-Fraumeni syndrome, in GeneReviews((R))\u00a0Adam MP et al (eds) Seattle (WA)"},{"issue":"1","key":"11177_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0194-70","volume":"6","author":"LM Mulligan","year":"1994","unstructured":"Mulligan LM et al (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nat Genet 6(1):70\u201374","journal-title":"Nat Genet"},{"issue":"12","key":"11177_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/jmedgenet-2016-103839","volume":"53","author":"MC Southey","year":"2016","unstructured":"Southey MC et al (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53(12):800\u2013811","journal-title":"J Med Genet"},{"issue":"5","key":"11177_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"1","key":"11177_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41698-023-00429-1","volume":"7","author":"N Tung","year":"2023","unstructured":"Tung N et al (2023) Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing. NPJ Precis Oncol 7(1):76","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"11177_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.13070","volume":"5","author":"TA Yap","year":"2022","unstructured":"Yap TA et al (2022) Prevalence of germline findings among tumors from cancer types lacking hereditary testing guidelines. JAMA Netw Open 5(5):e2213070","journal-title":"JAMA Netw Open"},{"issue":"24","key":"11177_CR8","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1200\/JCO.20.03661","volume":"39","author":"ZK Stadler","year":"2021","unstructured":"Stadler ZK et al (2021) Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol 39(24):2698\u20132709","journal-title":"J Clin Oncol"},{"key":"11177_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1200\/PO.19.00354","volume":"4","author":"BP Schneider","year":"2020","unstructured":"Schneider BP et al (2020) Implications of incidental germline findings identified in the context of clinical whole exome sequencing for guiding cancer therapy. JCO Precis Oncol 4:1109\u20131121","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"11177_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"KL Huang","year":"2018","unstructured":"Huang KL et al (2018) Pathogenic germline variants in 10,389 adult cancers. Cell 173(2):355-370 e14","journal-title":"Cell"},{"key":"11177_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190264","author":"D Jaber","year":"2025","unstructured":"Jaber D, Zhang J, Godley LA (2025) Detecting likely germline variants during tumor-based molecular profiling. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI190264","journal-title":"J Clin Invest"},{"issue":"1","key":"11177_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trecan.2019.11.006","volume":"6","author":"D Mandelker","year":"2020","unstructured":"Mandelker D, Ceyhan-Birsoy O (2020) Evolving significance of tumor-normal sequencing in cancer care. Trends Cancer 6(1):31\u201339","journal-title":"Trends Cancer"},{"issue":"4","key":"11177_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.annonc.2022.01.006","volume":"33","author":"P Terraf","year":"2022","unstructured":"Terraf P et al (2022) Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing. Ann Oncol 33(4):426\u2013433","journal-title":"Ann Oncol"},{"issue":"16_suppl","key":"11177_CR14","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1200\/JCO.2025.43.16_suppl.10568","volume":"43","author":"B Cooper","year":"2025","unstructured":"Cooper B et al (2025) Discrepancies between germline and somatic laboratories in the reporting of germline cancer predisposition variants. J Clin Oncol 43(16_suppl):10568\u201310568","journal-title":"J Clin Oncol"},{"issue":"10","key":"11177_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jmoldx.2025.06.005","volume":"27","author":"DK Manning","year":"2025","unstructured":"Manning DK et al (2025) Clinical implementation of matched tumor\/germline sequencing improves accuracy of tumor genomic profiling and therapeutic recommendations. J Mol Diagn 27(10):969\u2013988","journal-title":"J Mol Diagn"},{"issue":"7913","key":"11177_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","volume":"606","author":"MA Fabre","year":"2022","unstructured":"Fabre MA et al (2022) The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 606(7913):335\u2013342","journal-title":"Nature"},{"issue":"16_suppl","key":"11177_CR17","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1200\/JCO.2023.41.16_suppl.7072","volume":"41","author":"KS Chien","year":"2023","unstructured":"Chien KS et al (2023) Outcomes of individuals with clonal hematopoiesis evaluated at a cancer center. J Clin Oncol 41(16_suppl):7072\u20137072","journal-title":"J Clin Oncol"},{"issue":"21","key":"11177_CR18","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1200\/JCO.24.00662","volume":"42","author":"N Tung","year":"2024","unstructured":"Tung N et al (2024) Selection of germline genetic testing panels in patients with cancer: ASCO guideline. J Clin Oncol 42(21):2599\u20132615","journal-title":"J Clin Oncol"},{"key":"11177_CR19","unstructured":"Network NCCN (2026) Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate"},{"issue":"7","key":"11177_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565\u2013574","journal-title":"Genet Med"},{"issue":"D1","key":"11177_CR21","doi-asserted-by":"publisher","first-page":"D1313","DOI":"10.1093\/nar\/gkae1090","volume":"53","author":"MJ Landrum","year":"2025","unstructured":"Landrum MJ et al (2025) ClinVar: updates to support classifications of both germline and somatic variants. Nucleic Acids Res 53(D1):D1313\u2013D1321","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11177_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44526","volume":"7","author":"Y Kobayashi","year":"2024","unstructured":"Kobayashi Y et al (2024) Clinical variant reclassification in hereditary disease genetic testing. JAMA Netw Open 7(11):e2444526","journal-title":"JAMA Netw Open"},{"issue":"12","key":"11177_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1200\/OP.20.00431","volume":"16","author":"BM Szymaniak","year":"2020","unstructured":"Szymaniak BM et al (2020) Practical considerations and challenges for germline genetic testing in patients with prostate cancer: recommendations from the germline genetics working group of the PCCTC. JCO Oncol Pract 16(12):811\u2013819","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"11177_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1245\/s10434-024-16306-5","volume":"32","author":"HH Huston-Paterson","year":"2025","unstructured":"Huston-Paterson HH et al (2025) Medicaid coverage of NCCN- and ASCO\/SSO-guideline-concordant BRCA germline testing for patients with breast cancer: opportunity to embrace rapid advancements in precision medicine. Ann Surg Oncol 32(2):646\u2013649","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"11177_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.1250","volume":"29","author":"JM Peterson","year":"2020","unstructured":"Peterson JM et al (2020) Racial disparities in breast cancer hereditary risk assessment referrals. J Genet Couns 29(4):587\u2013593","journal-title":"J Genet Couns"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11177-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:49:06Z","timestamp":1792086546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11177-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11177"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11177-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LM is on the Scientific Advisory Board for Diploid Genomics Inc XZ has no competing interests to declare.\u00a0","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"947"}}